WG
GILD icon

Welch Group’s Gilead Sciences GILD Stock Holding History

Welch Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$594K Buy
4,699
+515
+12% +$67.9K 0.02% 171
2026
Q1 		$583K Hold
4,184
– – 0.02% 163
2025
Q4 		$514K Buy
4,184
+235
+6% +$28.6K 0.02% 171
2025
Q3 		$438K Buy
3,949
+66
+2% +$7.5K 0.02% 183
2025
Q2 		$431K Buy
3,883
+876
+29% +$93.2K 0.02% 170
2025
Q1 		$336K Sell
3,007
-1,132
-27% -$117K 0.01% 188
2024
Q4 		$381K Buy
4,139
+3
+0.1% +$270 0.02% 181
2024
Q3 		$347K Hold
4,136
– – 0.02% 190
2024
Q2 		$284K Hold
4,136
– – 0.01% 199
2024
Q1 		$303K Buy
4,136
+844
+26% +$64.9K 0.02% 178
2023
Q4 		$267K Hold
3,292
– – 0.01% 189
2023
Q3 		$247K Sell
3,292
-53
-2% -$4.08K 0.01% 177
2023
Q2 		$258K Sell
3,345
-318
-9% -$25.4K 0.01% 174
2023
Q1 		$304K Sell
3,663
-17
-0.5% -$1.41K 0.02% 153
2022
Q4 		$316K Sell
3,680
-336
-8% -$26.6K 0.02% 152
2022
Q3 		$248K Buy
4,016
+336
+9% +$21.2K 0.02% 148
2022
Q2 		$227K Hold
3,680
– – 0.01% 180
2022
Q1 		$219K Buy
3,680
+672
+22% +$43K 0.01% 197
2021
Q4 		$218K Buy
+3,008
New +$207K 0.01% 201
2020
Q3 		– Sell
-2,764
Closed -$213K – 144
2020
Q2 		$213K Buy
2,764
+1,087
+65% +$83.3K 0.02% 124
2020
Q1 		$125K Sell
1,677
-4,088
-71% -$282K 0.01% 139
2019
Q4 		$375K Buy
5,765
+585
+11% +$38.1K 0.04% 86
2019
Q3 		$328K Buy
5,180
+38
+0.7% +$2.48K 0.03% 92
2019
Q2 		$347K Sell
5,142
-3,498
-40% -$230K 0.04% 87
2019
Q1 		$562K Buy
8,640
+853
+11% +$56.7K 0.06% 68
2018
Q4 		$487K Buy
7,787
+1,078
+16% +$75.3K 0.06% 70
2018
Q3 		$518 Buy
6,709
+685
+11% +$51.7K 0.05% 72
2018
Q2 		$427K Buy
6,024
+457
+8% +$32.3K 0.05% 76
2018
Q1 		$420K Buy
5,567
+1,839
+49% +$146K 0.05% 77
2017
Q4 		$267K Buy
3,728
+259
+7% +$19.7K 0.04% 90
2017
Q3 		$281K Sell
3,469
-897
-21% -$68.6K 0.05% 80
2017
Q2 		$309K Buy
4,366
+1,509
+53% +$100K 0.05% 97
2017
Q1 		$194K Buy
2,857
+252
+10% +$17.7K 0.04% 85
2016
Q4 		$187K Buy
2,605
+30
+1% +$2.23K 0.04% 90
2016
Q3 		$204K Buy
2,575
+233
+10% +$18.9K 0.04% 87
2016
Q2 		$195K Sell
2,342
-479
-17% -$42.5K 0.04% 77
2016
Q1 		$269K Buy
2,821
+284
+11% +$25.6K 0.04% 86
2015
Q4 		$257K Buy
2,537
+247
+11% +$25.7K 0.05% 86
2015
Q3 		$225K Sell
2,290
-218
-9% -$24.2K 0.04% 88
2015
Q2 		$294K Buy
2,508
+135
+6% +$14.8K 0.06% 80
2015
Q1 		$233 Buy
2,373
+57
+2% +$5.79K 0.04% 96
2014
Q4 		$218K Sell
2,316
-1,628
-41% -$168K 0.04% 96
2014
Q3 		$420K Buy
3,944
+826
+26% +$80.9K 0.09% 66
2014
Q2 		$259K Sell
3,118
-40
-1% -$3.11K 0.05% 87
2014
Q1 		$224K Buy
3,158
+125
+4% +$9.8K 0.05% 85
2013
Q4 		$228K Sell
3,033
-652
-18% -$45.4K 0.05% 91
2013
Q3 		$232K Buy
3,685
+131
+4% +$7.83K 0.06% 84
2013
Q2 		$182K Buy
+3,554
New +$185K 0.05% 93

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Welch Group's GILD Position: Q2 2026 in Review

Welch Group increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $67.9K and bringing the position to 4,699 shares worth $594K. The position accounts for 0.02% of the portfolio, ranked #171.

Welch Group first reported a position in GILD in Q2 2013 and has held it in 48 quarters since. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Welch Group held 4,699 shares of Gilead Sciences worth $594K as of Q2 2026.
  • Welch Group bought 515 Gilead Sciences shares in Q2 2026, an estimated $67.9K.
  • Gilead Sciences made up 0.02% of Welch Group's portfolio in Q2 2026, its #171 holding.
  • Welch Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 48 quarters since.
  • 911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Welch Group's 13F filing for Q2 2026, filed 23 Jul 2026.